Galera Therapeutics, Inc.
Galera Therapeutics, Inc. (GRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRTX · as of Jun 15, 2026
Key Statistics
Explore Galera Therapeutics, Inc. Data
grtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 66.7%
Competitors & Peers
grtx competitorsGRTX
AGTX
ANTCF
EMBT
HEMP
HESGStock Performance
Full HistoryAbout Galera Therapeutics, Inc.
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead…
what is galera therapeutics, inc. · grtx stock overview · galera therapeutics, inc. company profile · who is galera therapeutics, inc. ceo · grtx OTC · galera therapeutics, inc. headquarters · galera therapeutics, inc. business segments
About Stock Overview & Key Data
Galera Therapeutics, Inc. (GRTX) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 7, 2019. As of the latest trading session, GRTX stock price is $0.09, with a market capitalization of $7.0M. The stock has returned +217.24% over the past 12 months and +318.18% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Galera Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Galera Therapeutics, Inc. reported revenue of — and net income of $149.0M. For detailed data — including Galera Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Galera Therapeutics, Inc. (GRTX) stock price is $0.09. The stock is traded on OTC under the ticker symbol GRTX. The 52-week range is $0.01 – $0.15.